RaySearch Laboratories AB (RSLBF)
18.85
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 633.69M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -32.47% |
| Valuation | |
| PE Ratio | 28.43 |
| PE Ratio (Forward) | |
| PS Ratio | 4.762 |
| Price to Book Value | 7.779 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.4369 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.4556 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 85.58% |
Profile
| RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. Its products and services are divided into three categories: RayStation, Partner Products, and Research. RayStation is the company's proprietary treatment planning system. Partner Products include proton and intensity modulated radiation therapy, automatic treatment planning, quality assurance, and radiobiology. Research offers long term study of new methods and techniques in radiation treatment. The company was founded by Johan Löf, Erik Hedlund, Carl Filip Bergendal, Anders Brahme, Bengt Lind, and Anders Liander in 2000 and is headquartered in Stockholm, Sweden. |
| URL | http://www.raysearchlabs.com |
| Investor Relations URL | N/A |
| HQ State/Province | Stockholm |
| Sector | Health Care |
| Industry | Health Care Technology |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Nov. 03, 2026 |
| Last Earnings Release | Aug. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 11, 2026 |
Profile
| RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. Its products and services are divided into three categories: RayStation, Partner Products, and Research. RayStation is the company's proprietary treatment planning system. Partner Products include proton and intensity modulated radiation therapy, automatic treatment planning, quality assurance, and radiobiology. Research offers long term study of new methods and techniques in radiation treatment. The company was founded by Johan Löf, Erik Hedlund, Carl Filip Bergendal, Anders Brahme, Bengt Lind, and Anders Liander in 2000 and is headquartered in Stockholm, Sweden. |
| URL | http://www.raysearchlabs.com |
| Investor Relations URL | N/A |
| HQ State/Province | Stockholm |
| Sector | Health Care |
| Industry | Health Care Technology |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Nov. 03, 2026 |
| Last Earnings Release | Aug. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 11, 2026 |